Invention Grant
- Patent Title: Guanidinobenzoic acid ester compound
-
Application No.: US14775274Application Date: 2014-03-13
-
Publication No.: US09969709B2Publication Date: 2018-05-15
- Inventor: Jiro Fujiyasu , Toru Asano , Susumu Yamaki , Osamu Kaneko , Yuka Koike , Tomoyoshi Imaizumi , Yasuharu Urano , Tomohki Satou , Satoshi Sasamura
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JP2013-050011 20130313
- International Application: PCT/JP2014/056601 WO 20140313
- International Announcement: WO2014/142219 WO 20140918
- Main IPC: C07D333/70
- IPC: C07D333/70 ; C07D279/18 ; C07D333/24 ; C07D333/68 ; C07D217/26 ; C07D333/40 ; C07D307/81 ; A61K31/24 ; A61K31/343 ; A61K31/381 ; A61K31/472 ; C07C279/18

Abstract:
[Problem]To provide a compound which is useful as an agent for preventing and/or treating kidney diseases.[Means for Solution]The present inventors have studied compounds having a trypsin inhibitory activity, and have confirmed that a guanidinobenzoic acid ester compound has a trypsin inhibitory activity, thereby completing the present invention. The guanidinobenzoic acid ester compound of the present invention can be used as an agent for preventing and/or treating kidney diseases (for example, chronic kidney disease, acute glomerulonephritis, acute kidney injury, and the like) as an agent which will substitute low-protein diet therapy, and/or as an agent for preventing and/or treating trypsin-related diseases (for example, chronic pancreatitis, gastroesophageal reflux disease, hepatic encephalopathy, influenza, and the like).
Public/Granted literature
- US20160031847A1 GUANIDINOBENZOIC ACID ESTER COMPOUND Public/Granted day:2016-02-04
Information query